January 4, 2025 · Form 4 insider transaction
O'Brien Patrick bought 100,000 shares of Arrowhead Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Represents shares underlying restricted stock units with a grant date 01/04/2025, which will vest in four equal annual installments.